CANDICE MCCOOL: Open Payments
NPI 1104224294 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,344 in 44 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $31 · 2025 $1,344
Food & beverage: $1,344
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $382 |
| GENZYME CORPORATION | 6 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $161 |
| Incyte Corporation | 2 | $159 |
| Novartis Pharmaceuticals Corporation | 4 | $73 |
| Grifols USA, LLC | 3 | $69 |
| Regeneron Healthcare Solutions, Inc. | 2 | $65 |
| Genentech USA, Inc. | 3 | $63 |
| CSL Behring | 2 | $42 |
| Lilly USA, LLC | 1 | $25 |
Products named: DUPIXENT, AIRSUPRA, FASENRA, TEZSPIRE, Prolastin-C Liquid, Xolair, Hizentra, Rhapsido.
Industry payments across MO — which companies pay providers there.
